https://www.sciencealert.com/how-covid-disturbs-br
Post# of 148155
Interesting article on the neurological affects of Covid-19, especially those experienced by long-haulers.
There is the open question "this impairment could be the result of widespread inflammation, as the body mounts its immune response, or possibly reduced blood flow to the brain, if the heart and lungs are weak." In my opinion, leronlimab could tackle both scenarios with its immunomodulating MOA and also its potential to cross the BBB.